☰

Joyce C. Solheim - Publications

Affiliations: 
University of Nebraska Medical Center, Omaha, NE, United States 
Area:
Biochemistry, Molecular Biology, Immunology
Website:
https://www.unmc.edu/eppley/about/faculty/solheim.html
Tree Info Similar researchers PubMed Report error

67 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Knoche SM, Larson AC, Brumfield GL, Cate S, Hildebrand WH, Solheim JC. Correction: Major histocompatibility complex class I molecule expression by pancreatic cancer cells is regulated by activation and inhibition of the epidermal growth factor receptor. Immunologic Research. PMID 38051459 DOI: 10.1007/s12026-023-09442-9  0.318
2022 Knoche SM, Larson AC, Brumfield GL, Cate S, Hildebrand WH, Solheim JC. Major histocompatibility complex class I molecule expression by pancreatic cancer cells is regulated by activation and inhibition of the epidermal growth factor receptor. Immunologic Research. PMID 35303241 DOI: 10.1007/s12026-022-09262-3  0.387
2020 Poelaert BJ, Romanova S, Knoche SM, Olson MT, Sliker BH, Smits K, Dickey BL, Moffitt-Holida AEJ, Goetz BT, Khan N, Smith L, Band H, Mohs AM, Coulter DW, Bronich TK, ... Solheim JC, et al. Nanoformulation of CCL21 greatly increases its effectiveness as an immunotherapy for neuroblastoma. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 32711026 DOI: 10.1016/J.Jconrel.2020.07.024  0.349
2020 Sliker BH, Goetz BT, Barnes R, King H, Maurer HC, Olive KP, Solheim JC. HLA-B influences integrin beta-1 expression and pancreatic cancer cell migration. Experimental Cell Research. 111960. PMID 32194036 DOI: 10.1016/J.Yexcr.2020.111960  0.474
2019 Banerjee K, Gautam SK, Kshirsagar P, Ross KA, Spagnol G, Sorgen P, Wannemuehler MJ, Narasimhan B, Solheim JC, Kumar S, Batra SK, Jain M. Amphiphilic polyanhydride-based recombinant MUC4β-nanovaccine activates dendritic cells. Genes & Cancer. 10: 52-62. PMID 31258832 DOI: 10.18632/Genesandcancer.189  0.391
2019 Sliker BH, Goetz BT, Peters HL, Poelaert BJ, Borgstahl GEO, Solheim JC. Beta 2-microglobulin regulates amyloid precursor-like protein 2 expression and the migration of pancreatic cancer cells. Cancer Biology & Therapy. 1-10. PMID 30810435 DOI: 10.1080/15384047.2019.1580414  0.788
2019 Bhatia R, Gautam SK, Cannon A, Thompson C, Hall BR, Aithal A, Banerjee K, Jain M, Solheim JC, Kumar S, Batra SK. Cancer-associated mucins: role in immune modulation and metastasis. Cancer Metastasis Reviews. PMID 30618016 DOI: 10.1007/S10555-018-09775-0  0.435
2018 Sliker B, Liu C, Poelaert B, Goetz B, Solheim JC. Abstract B028: Beta 2-microglobulin promotes human pancreatic cancer cell migration Molecular Cancer Therapeutics. 17. DOI: 10.1158/1535-7163.Targ-17-B028  0.459
2017 Banerjee K, Kumar S, Ross KA, Gautam S, Poelaert B, Nasser MW, Aithal A, Bhatia R, Wannemuehler MJ, Narasimhan B, Solheim JC, Batra SK, Jain M. Emerging trends in the immunotherapy of pancreatic cancer. Cancer Letters. PMID 29242097 DOI: 10.1016/J.Canlet.2017.12.012  0.377
2017 Sliker B, Liu C, Poelaert B, Maurer HC, Olive KP, Solheim JC. Abstract 3710: Components of HLA class I molecules influence pancreatic cancer cell proliferation and migration Cancer Research. 77: 3710-3710. DOI: 10.1158/1538-7445.Am2017-3710  0.504
2016 Pandey P, Sliker B, Peters HL, Tuli A, Herskovitz J, Smits K, Purohit A, Singh RK, Dong J, Batra SK, Coulter DW, Solheim JC. Amyloid precursor protein and amyloid precursor-like protein 2 in cancer. Oncotarget. PMID 26840089 DOI: 10.18632/Oncotarget.7103  0.774
2015 Pandey P, Rachagani S, Das S, Seshacharyulu P, Sheinin Y, Naslavsky N, Pan Z, Smith BL, Peters HL, Radhakrishnan P, McKenna NR, Giridharan SS, Haridas D, Kaur S, Hollingsworth MA, ... ... Solheim JC, et al. Amyloid precursor-like protein 2 (APLP2) affects the actin cytoskeleton and increases pancreatic cancer growth and metastasis. Oncotarget. 6: 2064-75. PMID 25576918 DOI: 10.18632/Oncotarget.2990  0.758
2013 Peters HL, Yan Y, Solheim JC. APLP2 regulates the expression of MHC class I molecules on irradiated Ewing's sarcoma cells. Oncoimmunology. 2: e26293. PMID 24353913 DOI: 10.4161/Onci.26293  0.806
2013 Peters HL, Yan Y, Nordgren TM, Cutucache CE, Joshi SS, Solheim JC. Amyloid precursor-like protein 2 suppresses irradiation-induced apoptosis in Ewing sarcoma cells and is elevated in immune-evasive Ewing sarcoma cells. Cancer Biology & Therapy. 14: 752-60. PMID 23792571 DOI: 10.4161/Cbt.25183  0.747
2012 Simone LC, Smith BL, Solheim JC. Impact of beta 2-microglobulin on tapasin expression and covalent association. Cellular Immunology. 279: 66-9. PMID 23089196 DOI: 10.1016/J.Cellimm.2012.09.010  0.756
2012 Peters HL, Tuli A, Wang X, Liu C, Pan Z, Ouellette MM, Hollingsworth MA, Macdonald RG, Solheim JC. Relevance of amyloid precursor-like protein 2 C-terminal fragments in pancreatic cancer cells. International Journal of Oncology. 41: 1464-74. PMID 22797723 DOI: 10.3892/Ijo.2012.1553  0.789
2012 Simone LC, Tuli A, Simone PD, Wang X, Solheim JC. Analysis of major histocompatibility complex class I folding: novel insights into intermediate forms. Tissue Antigens. 79: 249-62. PMID 22329842 DOI: 10.1111/J.1399-0039.2012.01849.X  0.815
2012 Simone LC, Georgesen CJ, Simone PD, Wang X, Solheim JC. Productive association between MHC class I and tapasin requires the tapasin transmembrane/cytosolic region and the tapasin C-terminal Ig-like domain. Molecular Immunology. 49: 628-39. PMID 22169163 DOI: 10.1016/J.Molimm.2011.11.002  0.764
2011 Peters HL, Tuli A, Sharma M, Naslavsky N, Caplan S, MacDonald RG, Solheim JC. Regulation of major histocompatibility complex class I molecule expression on cancer cells by amyloid precursor-like protein 2. Immunologic Research. 51: 39-44. PMID 21826533 DOI: 10.1007/S12026-011-8238-6  0.82
2010 Simone LC, Wang X, Tuli A, Solheim JC. Effect of a tapasin mutant on the assembly of the mouse MHC class I molecule H2-K(d). Immunology and Cell Biology. 88: 57-62. PMID 19687800 DOI: 10.1038/Icb.2009.59  0.83
2010 Abe F, Dafferner AJ, Donkor M, Westphal SN, Scholar EM, Solheim JC, Singh RK, Hoke TA, Talmadge JE. Myeloid-derived suppressor cells in mammary tumor progression in FVB Neu transgenic mice. Cancer Immunology, Immunotherapy : Cii. 59: 47-62. PMID 19449184 DOI: 10.1007/S00262-009-0719-2  0.394
2009 Tuli A, Sharma M, Capek HL, Naslavsky N, Caplan S, Solheim JC. Mechanism for amyloid precursor-like protein 2 enhancement of major histocompatibility complex class I molecule degradation. The Journal of Biological Chemistry. 284: 34296-307. PMID 19808674 DOI: 10.1074/Jbc.M109.039727  0.736
2009 Wang X, Simone LC, Tuli A, Solheim JC. Comparative analysis of the impact of a free cysteine in tapasin on the maturation and surface expression of murine MHC class I allotypes. International Journal of Immunogenetics. 36: 183-7. PMID 19490214 DOI: 10.1111/J.1744-313X.2009.00840.X  0.831
2009 Donkor MK, Lahue E, Hoke TA, Shafer LR, Coskun U, Solheim JC, Gulen D, Bishay J, Talmadge JE. Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells. International Immunopharmacology. 9: 937-48. PMID 19362167 DOI: 10.1016/J.Intimp.2009.03.021  0.368
2009 Simone LC, Wang X, Solheim JC. A transmembrane tail: interaction of tapasin with TAP and the MHC class I molecule. Molecular Immunology. 46: 2147-50. PMID 19361863 DOI: 10.1016/J.Molimm.2009.03.006  0.766
2009 Tuli A, Sharma M, Wang X, Simone LC, Capek HL, Cate S, Hildebrand WH, Naslavsky N, Caplan S, Solheim JC. Amyloid precursor-like protein 2 association with HLA class I molecules. Cancer Immunology, Immunotherapy : Cii. 58: 1419-31. PMID 19184004 DOI: 10.1007/S00262-009-0657-Z  0.834
2009 Simone LC, Wang X, Tuli A, McIlhaney MM, Solheim JC. Influence of the tapasin C terminus on the assembly of MHC class I allotypes. Immunogenetics. 61: 43-54. PMID 18958466 DOI: 10.1007/S00251-008-0335-X  0.827
2009 Lin X, Wang X, Capek HL, Simone LC, Tuli A, Morris CR, Reber AJ, Solheim JC. Effect of invariant chain on major histocompatibility complex class I molecule expression and stability on human breast tumor cell lines. Cancer Immunology, Immunotherapy : Cii. 58: 729-36. PMID 18828016 DOI: 10.1007/S00262-008-0595-1  0.805
2009 Tuli A, Sharma M, Wang X, Simone LC, Capek HL, Cate S, Hildebrand WH, Naslavsky N, Caplan S, Solheim JC. Erratum to: Amyloid precursor-like protein 2 association with HLA class I molecules Cancer Immunology, Immunotherapy. 59: 339-339. DOI: 10.1007/S00262-009-0777-5  0.807
2008 Tuli A, Sharma M, McIlhaney MM, Talmadge JE, Naslavsky N, Caplan S, Solheim JC. Amyloid precursor-like protein 2 increases the endocytosis, instability, and turnover of the H2-K(d) MHC class I molecule. Journal of Immunology (Baltimore, Md. : 1950). 181: 1978-87. PMID 18641335 DOI: 10.4049/Jimmunol.181.3.1978  0.758
2008 Tuli A, Sharma M, Naslavsky N, Caplan S, Solheim JC. Specificity of amyloid precursor-like protein 2 interactions with MHC class I molecules. Immunogenetics. 60: 303-13. PMID 18452037 DOI: 10.1007/S00251-008-0296-0  0.771
2007 Ashour AE, Lin X, Wang X, Turnquist HR, Burns NM, Tuli A, Sadanandam A, Suleiman K, Singh RK, Talmadge JE, Solheim JC. CCL21 is an effective surgical neoadjuvant for treatment of mammary tumors. Cancer Biology & Therapy. 6: 1206-10. PMID 17617742 DOI: 10.4161/Cbt.6.8.4405  0.756
2007 Ashour AE, Turnquist HR, Burns N, Wang X, Lin X, Tremayne J, Hollingsworth MA, Blonder JM, Rosenthal GJ, Talmadge JE, Solheim JC. Flt3 ligand delivered in a pluronic formulation prolongs the survival of mice with orthotopic pancreatic adenocarcinoma. Cancer Biotherapy & Radiopharmaceuticals. 22: 235-8. PMID 17600470 DOI: 10.1089/Cbr.2007.336  0.768
2007 Turnquist HR, Lin X, Ashour AE, Hollingsworth MA, Singh RK, Talmadge JE, Solheim JC. CCL21 induces extensive intratumoral immune cell infiltration and specific anti-tumor cellular immunity. International Journal of Oncology. 30: 631-9. PMID 17273764 DOI: 10.3892/Ijo.30.3.631  0.772
2007 Solheim JC, Reber AJ, Ashour AE, Robinson S, Futakuchi M, Kurz SG, Hood K, Fields RR, Shafer LR, Cornell D, Sutjipto S, Zurawski S, LaFace DM, Singh RK, Talmadge JE. Spleen but not tumor infiltration by dendritic and T cells is increased by intravenous adenovirus-Flt3 ligand injection. Cancer Gene Therapy. 14: 364-71. PMID 17235356 DOI: 10.1038/Sj.Cgt.7701018  0.68
2007 Ashour AE, Turnquist HR, Singh RK, Talmadge JE, Solheim JC. CCL21-induced immune cell infiltration. International Immunopharmacology. 7: 272-6. PMID 17178395 DOI: 10.1016/J.Intimp.2006.10.004  0.751
2005 Chen Z, Varney ML, Backora MW, Cowan K, Solheim JC, Talmadge JE, Singh RK. Down-regulation of vascular endothelial cell growth factor-C expression using small interfering RNA vectors in mammary tumors inhibits tumor lymphangiogenesis and spontaneous metastasis and enhances survival. Cancer Research. 65: 9004-11. PMID 16204074 DOI: 10.1158/0008-5472.Can-05-0885  0.357
2005 Ambagala AP, Solheim JC, Srikumaran S. Viral interference with MHC class I antigen presentation pathway: the battle continues. Veterinary Immunology and Immunopathology. 107: 1-15. PMID 15978672 DOI: 10.1016/J.Vetimm.2005.04.006  0.47
2005 Sang H, Pisarev VM, Chavez J, Robinson S, Guo Y, Hatcher L, Munger C, Talmadge CB, Solheim JC, Singh RK, Talmadge JE. Murine mammary adenocarcinoma cells transfected with p53 and/or Flt3L induce antitumor immune responses. Cancer Gene Therapy. 12: 427-37. PMID 15678151 DOI: 10.1038/Sj.Cgt.7700809  0.377
2005 Petersen JL, Hickman-Miller HD, McIlhaney MM, Vargas SE, Purcell AW, Hildebrand WH, Solheim JC. A charged amino acid residue in the transmembrane/cytoplasmic region of tapasin influences MHC class I assembly and maturation. Journal of Immunology (Baltimore, Md. : 1950). 174: 962-9. PMID 15634919 DOI: 10.4049/Jimmunol.174.2.962  0.53
2004 Morris CR, Reber AJ, Petersen JL, Vargas SE, Solheim JC. Association of intracellular proteins with folded major histocompatibility complex class I molecules. Immunologic Research. 30: 171-9. PMID 15477658 DOI: 10.1385/Ir:30:2:171  0.533
2004 Reber AJ, Ashour AE, Robinson SN, Talmadge JE, Solheim JC. Flt3 ligand bioactivity and pharmacology in neoplasia. Current Drug Targets. Immune, Endocrine and Metabolic Disorders. 4: 149-56. PMID 15180455 DOI: 10.2174/1568008043339956  0.649
2004 Turnquist HR, Kohlgraf KG, McIlhaney MM, Mosley RL, Hollingsworth MA, Solheim JC. Tapasin decreases immune responsiveness to a model tumor antigen. Journal of Clinical Immunology. 24: 462-70. PMID 15163903 DOI: 10.1023/B:Joci.0000029118.51587.D9  0.737
2004 Turnquist HR, Petersen JL, Vargas SE, McIlhaney MM, Bedows E, Mayer WE, Grandea AG, Van Kaer L, Solheim JC. The Ig-like domain of tapasin influences intermolecular interactions. Journal of Immunology (Baltimore, Md. : 1950). 172: 2976-84. PMID 14978101 DOI: 10.4049/Jimmunol.172.5.2976  0.664
2003 Petersen JL, Morris CR, Solheim JC. Virus evasion of MHC class I molecule presentation. Journal of Immunology (Baltimore, Md. : 1950). 171: 4473-8. PMID 14568919 DOI: 10.4049/Jimmunol.171.9.4473  0.439
2003 Morris CR, Petersen JL, Vargas SE, Turnquist HR, McIlhaney MM, Sanderson SD, Bruder JT, Yu YY, Burgert HG, Solheim JC. The amyloid precursor-like protein 2 and the adenoviral E3/19K protein both bind to a conformational site on H-2Kd and regulate H-2Kd expression. The Journal of Biological Chemistry. 278: 12618-23. PMID 12506118 DOI: 10.1074/Jbc.M208203200  0.658
2002 Hildebrand WH, Turnquist HR, Prilliman KR, Hickman HD, Schenk EL, McIlhaney MM, Solheim JC. HLA class I polymorphism has a dual impact on ligand binding and chaperone interaction. Human Immunology. 63: 248-55. PMID 12039406 DOI: 10.1016/S0198-8859(02)00364-6  0.693
2002 Reber AJ, Turnquist HR, Thomas HJ, Lutz CT, Solheim JC. Expression of invariant chain can cause an allele-dependent increase in the surface expression of MHC class I molecules. Immunogenetics. 54: 74-81. PMID 12037599 DOI: 10.1007/S00251-002-0446-8  0.698
2002 Turnquist HR, Vargas SE, Schenk EL, McIlhaney MM, Reber AJ, Solheim JC. The interface between tapasin and MHC class I: identification of amino acid residues in both proteins that influence their interaction. Immunologic Research. 25: 261-9. PMID 12018464 DOI: 10.1385/Ir:25:3:261  0.697
2002 Turnquist HR, Vargas SE, McIlhaney MM, Li S, Wang P, Solheim JC. Calreticulin binds to the alpha1 domain of MHC class I independently of tapasin. Tissue Antigens. 59: 18-24. PMID 11972874 DOI: 10.1034/J.1399-0039.2002.590104.X  0.686
2002 Turnquist HR, Schenk EL, McIlhaney MM, Hickman HD, Hildebrand WH, Solheim JC. Disparate binding of chaperone proteins by HLA-A subtypes. Immunogenetics. 53: 830-4. PMID 11862383 DOI: 10.1007/S00251-001-0404-X  0.668
2001 Turnquist HR, Vargas SE, Solheim JC. Loss of a glycine in the alpha2 domain affects MHC peptide binding but not chaperone binding. Biochemical and Biophysical Research Communications. 289: 825-31. PMID 11735120 DOI: 10.1006/Bbrc.2001.6060  0.654
2001 Turnquist HR, Vargas SE, Reber AJ, McIlhaney MM, Li S, Wang P, Sanderson SD, Gubler B, van Endert P, Solheim JC. A region of tapasin that affects L(d) binding and assembly. Journal of Immunology (Baltimore, Md. : 1950). 167: 4443-9. PMID 11591770 DOI: 10.4049/Jimmunol.167.8.4443  0.637
2001 Harris MR, Lybarger L, Myers NB, Hilbert C, Solheim JC, Hansen TH, Yu YY. Interactions of HLA-B27 with the peptide loading complex as revealed by heavy chain mutations. International Immunology. 13: 1275-82. PMID 11581172 DOI: 10.1093/Intimm/13.10.1275  0.5
2001 Turnquist HR, Solheim JC. Analysis of major histocompatibility complex class I interactions with endoplasmic reticulum proteins. Methods in Molecular Biology (Clifton, N.J.). 156: 165-73. PMID 11068758 DOI: 10.1385/1-59259-062-4:165  0.65
2000 Turnquist HR, Thomas HJ, Prilliman KR, Lutz CT, Hildebrand WH, Solheim JC. HLA-B polymorphism affects interactions with multiple endoplasmic reticulum proteins. European Journal of Immunology. 30: 3021-8. PMID 11069086 DOI: 10.1002/1521-4141(200010)30:10<3021::Aid-Immu3021>3.0.Co;2-U  0.642
2000 Hansen T, Balendiran G, Solheim J, Ostrov D, Nathenson S. Structural features of MHC class I molecules that might facilitate alternative pathways of presentation. Immunology Today. 21: 83-8. PMID 10652466 DOI: 10.1016/S0167-5699(98)01426-1  0.595
2000 Solheim JC. Class I MHC molecules: assembly and antigen presentation. Immunological Reviews. 172: 11-9. PMID 10631933 DOI: 10.1111/J.1600-065X.1999.Tb01352.X  0.478
1999 Yu YY, Turnquist HR, Myers NB, Balendiran GK, Hansen TH, Solheim JC. An extensive region of an MHC class I alpha 2 domain loop influences interaction with the assembly complex. Journal of Immunology (Baltimore, Md. : 1950). 163: 4427-33. PMID 10510384  0.669
1997 Balendiran GK, Solheim JC, Young AC, Hansen TH, Nathenson SG, Sacchettini JC. The three-dimensional structure of an H-2Ld-peptide complex explains the unique interaction of Ld with beta-2 microglobulin and peptide. Proceedings of the National Academy of Sciences of the United States of America. 94: 6880-5. PMID 9192660 DOI: 10.1073/Pnas.94.13.6880  0.606
1996 Solheim JC, Cook JR, Hansen TH. Conformational changes induced in the MHC class I molecule by peptide and beta 2-microglobulin. Immunologic Research. 14: 200-17. PMID 8778210 DOI: 10.1007/BF02918217  0.369
1995 Smith JD, Solheim JC, Carreno BM, Hansen TH. Characterization of class I MHC folding intermediates and their disparate interactions with peptide and beta 2-microglobulin. Molecular Immunology. 32: 531-40. PMID 7783756 DOI: 10.1016/0161-5890(95)00013-5  0.422
1995 Solheim JC, Johnson NA, Carreno BM, Lie WR, Hansen TH. β2-microglobulin with an endoplasmic reticulum retention signal increases the surface expression of folded class I major histocompatibility complex molecules European Journal of Immunology. 25: 3011-3016. PMID 7489736 DOI: 10.1002/Eji.1830251104  0.505
1993 Solheim JC, Alexander-Miller MA, Martinko JM, Connolly JM. Biased T Cell Receptor Usage by Ld-Restricted, Tum- Peptide-Specific Cytotoxic T Lymphocyte Clones Journal of Immunology. 150: 800-811. PMID 8380825  0.739
1993 Solheim JC, Carreno BM, Smith JD, Gorka J, Myers NB, Wen Z, Martinko JM, Lee DR, Hansen TH. Binding of peptides lacking consensus anchor residue alters H-2Ld serologic recognition Journal of Immunology. 151: 5387-5397. PMID 7693810  0.752
1988 Martinko JM, Solheim JC, Geliebter J. The H-2Kkml mutation: A single nucleotide substitution is responsible for multiple functional differences in a class I MHC molecule Molecular Immunology. 25: 267-274. PMID 3374494 DOI: 10.1016/0161-5890(88)90018-1  0.751
1987 Martinko JM, Solheim JC, Geliebter J. The H-ZKkm1 mutation: Nucleotide sequence and comparative analysis Molecular Immunology. 24: 197-200. PMID 3614211 DOI: 10.1016/0161-5890(87)90092-7  0.726
Show low-probability matches.